Gilead"s virology drug head named CEO of East Coast biotech AlloVir

Gilead Sciences shares surged Friday morning following a media report detailing encouraging partial data from trials of the biotech company's experimental drug remdesivir in severe COVID-19 patients. Fred Katayama reports......»»

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) Biomerica, Inc. (NASDAQ: BMRA) Centogene NV (NASDAQ: CNTG) Gilead Sciences, Inc. (NA.....»»

Kyodo News via Getty Images Biotech company Gilead soared as much as 6.9% Monday morning after a World Health Organization official made .....»»

Boston-based DataRobot has named former AppDynamics executive Dan Wright as president and chief operating officer. He will be based in San Francisco. Wright, previously COO of San Francisco-based AppDynamics, joins DataRobot as it rapidly grows its .....»»

Wuhan Institute Of Virology And Chinese Army Submit Patent For Gilead Anti-Ebola Drug To Fight Coronavirus Amid growing speculation that nCoV-2019, aka novel coronavirus, aka.....»»

Krystal Biotech announced Tuesday that it had named Jennifer Chien to the newly created position of chief commercial officer, effective Monday. Chien joins the Pittsburgh-based gene therapy company after serving as vice president, head of geneti.....»»

Aduro Biotech Inc. will cut nearly 60% of its workforce and close its European office a month after Swiss partner Novartis AG stepped away from a four-year cancer drug collaboration. The Berkeley company (NASDAQ: ADRO) said the restructuring would cut.....»»

A rapid-fire cystic-fibrosis drug approval and crucial U.K. deal deliver a double dose of good news for Vertex Pharmaceuticals......»»

The following is a roundup of top developments in the biotech space over the last 24 hours.  Scaling The Peaks (Biotech stocks that hit 52-week highs Oct. 10.) read more.....»»

Midwest technology investors have spent the past decade trying to attract venture capitalists from Silicon Valley and the East Coast to homegrown startups. An early-stage investor from Indiana who's expanded to Columbus turns the model on its head......»»

The company's stock dropped 20 percent in April. Now it has largely recovered and is lining up to ask the FDA to approve its drug for Dravet syndrome......»»

The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership.....»»

Rick Polivy and his family have a special interest in Genentech's new cancer-fighting drug......»»

Barclays has named Gabriel Gruber as the new head of its chemicals banking team for Europe and the Middle East as it seeks to win more business after advising the likes of Evonik on their recent disposals, a source familiar with the matter said......»»

Swiss pharmaceuticals giant Novartis named Marie-France Tschudin head of its main drugs business after its previous manager, Paul Hudson, was poised to take the CEO position at French drugmaker Sanofi......»»

The celebrated public charter school in East Lake has hired its next leader from within its own ranks. The Charles R. Drew Charter School Board of Directors said it named Peter McKnight as its new head of school, succeeding Don Doran who is retiri.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 10) read more.....»»

At least 22 illnesses have been reported in the East Coast, the Food and Drug Administration said Friday......»»

Biotech Analysis Central Pharma News: Roche Abandons Drug, Gilead"s Early Stage Bet, Vaxart"s Phase 2 Failure.....»»

Charlottesville-based Social SafeGuard recently raised $11 million from a pair of Silicon Valley venture funds......»»